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Introduction
P
roteomics is deﬁned as the protein complement of the
genome and involves the complete analysis of all the
proteins in a given sample [1,2]. Several technologies
are involved, and numerous questions concerning the
proteins are addressed. What proteins are contained in a
biological sample? At what concentration do the proteins
exist? How do protein expression levels alter in different
samples? What are the posttranslational modiﬁcations
(PTMs)? Where in the cell [3] or an organism [4] are the
proteins localised? How do the proteins interact with other
proteins or molecules [5,6]?
The following discussion concentrates on computational
aspects of protein identiﬁcation. Characterization
(identiﬁcation of protein modiﬁcations), quantitation, and
sample comparisons are also discussed brieﬂy.
A typical proteomic experiment involves the analysis of
complex samples, i.e., containing many proteins at varying
concentrations [7]. Most of the currently available technology
for identifying proteins from biological samples simply
cannot contend with the complexity, and the majority of the
low-abundance proteins are not observed. There are,
however, a number of methods to separate the proteins
contained in the original sample to obtain a simpler sample
set that is amenable to in-depth analyses. Typical
technologies are electrophoretic gels [8] and liquid
chromatography [9] (LC) (see Figure 1A).
A dominant and well-practiced technique in proteomics is
referred to as the ‘‘bottom-up’’ approach. Proteins are
digested into peptides (smaller components of the protein) by
a proteolytic enzyme, e.g., trypsin. Analysis of the peptides is
achieved by mass spectrometry (MS), and, from the data
generated, the peptides (and subsequently the proteins) can
be identiﬁed. The resultant mixture of peptides obtained
from the digestion of several proteins is often highly complex,
and a degree of separation can be achieved by peptide LC.
Possible combinations of separation techniques are
illustrated in Figure 1B.
Mass spectrometers comprise three main components: an
ion-source, a fragmentation cell, and a mass analyzer. Each
component is essentially independent from the others, and as
such it is possible to combine the different technological
aspects to produce different types of mass spectrometers. To
measure its molecular mass, a molecule must be ionised. This
occurs in the ion source of the mass spectrometer. The source
can be based either on electrospray ionization [10] (ESI),
which is therefore appropriate for liquid samples; or on
matrix assisted laser desorption ionization [11] (MALDI),
which is appropriate for samples that have been mixed with a
matrix and crystallized on a metallic plate. The most common
types of mass analyzers used in proteomic laboratories are (i)
ion trap (IT), where the radio frequency of the trap is varied
and the ejected ions are detected; and (ii) time-of-ﬂight (TOF)
analyzers, where the time required for an ion to ‘‘ﬂy’’ through
an electric ﬁeld–free region of the instrument is recorded
and correlated to the mass of the ion. Most current
instruments include a fragmentation cell that uses an inert
gas to break the peptides by collision-induced dissociation
(CID). A fragmentation cell, however, is not always present
(see next section), or fragmentation can occur
‘‘spontaneously’’ (in-source and post-source decay). All mass
spectrometers do not measure mass directly, but rather the
mass-to-charge ratio. Hence the measurements obtained are
dependent on the charge state(s) of the molecule.
Peptide Mass Fingerprinting
Separation of proteins by 2-D gel electrophoresis produces
numerous spots that essentially contain one dominant
protein. It is possible to enzymatically digest the protein in
situ and measure peptide masses by MS. Historically, mass
measurement of the digested proteins was initially performed
with a matrix assisted laser desorption ionisation time-of-
ﬂight (MALDI-TOF) instrument. The ions generated by
MALDI-TOF-MS are predominantly singly charged;
therefore, the mass of the peptide can be easily calculated.
Once the mass spectrum that is obtained has been signal-
processed, a list of peptide experimental masses is generated
(see the next section, Peak Detection). This mass list is also
referred to as the experimental spectrum. The data generated
can be searched against a protein database by comparing
each protein sequence with the experimental peptide mass
list. The comparison requires computation of a theoretical
mass spectrum by digesting the sequence in silico and
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to measure the correlation between experimental and
theoretical data. The highest-scoring sequence is assumed to
be correct [12–14] (see Figure 2). In addition to the score, it is
sometimes possible to estimate a p-value for the match
between experimental and theoretical data.
The procedure described in the previous paragraph,
named peptide mass ﬁngerprinting (PMF), relies on a site-
speciﬁc enzyme that cleaves at precise locations in the
proteins. For example, trypsin cleaves after both lysine and
arginine residues, provided the next amino acid in the
sequence is not a proline residue.
Conceptually, PMF is straightforward and clearly
introduces the principle of MS data identiﬁcation by database
searching. Nevertheless, when searching large databases, or
when the number of available peptides is limited, the risk of
false positive identiﬁcation becomes increasingly higher. The
presence of modiﬁed (PTMs) or incompletely cleaved
peptides further reduces PMF data speciﬁcity. Moreover, the
experimental design may not be amenable to 2-D gel analysis,
and as such the assumption that one protein is analyzed at a
time is no longer valid. Therefore, an MS technology that
allows more than single protein analysis and provides
additional information on each peptide would be a marked
improvement over PMF.
Two programs and a parameter ﬁle (Text S1–S3) and a
mass list (Text S4) are provided to illustrate the
implementation of a simple PMF search algorithm.
Peak Detection
The program extracting a list of masses from an
experimental spectrum (usually provided by the MS
instrument manufacturer) is essential in the identiﬁcation of
MS data. The performance of the algorithm and the quality of
the data produced play an important role in both database
searching and de novo sequencing. There are several methods
to extract masses that range from straightforward local
maximum detection to sophisticated wavelet analysis.
In Figure 3, a successful method for MALDI-PMF peak
detection is illustrated. Successive isotopic peaks are
identiﬁed simultaneously by ﬁtting a global model. Limited
resolution of certain instruments and multiple charge states
observed in ESI-MS cause additional difﬁculties. Such issues
can make peak detection more problematic than that
suggested in Figure 3.
Tandem Mass Spectrometry
From the point of view of data processing, tandem mass
spectrometry (MS/MS) can be introduced as an additional
level to mass ﬁngerprinting. There are ways that peptides can
be broken into smaller molecules (fragments). As the
fragmentation process is governed by certain rules, the set of
fragment masses constitutes speciﬁc data. By taking
advantage of such peptide-speciﬁc mass sets, it is possible to
identify the peptides.
The peptide fragmentation process can be induced in
doi:10.1371/journal.pcbi.0030114.g001
Figure 1. Steps in Sample Analysis by Proteomics
(A) Sample complexity reduction via an LC column. This is applicable to both proteins and peptides. It is possible to collect fractions at fixed or variable
time intervals to obtain a series of less complex samples; however, direct MS analysis is also an option. The figure illustrates how peptides/proteins 1–11
are fractionated.
(B) Major steps in ‘‘bottom-up’’ proteomics and combinations thereof. Optional steps and essential steps are in rounded and bold rectangles,
respectively. Green represents shotgun peptide sequencing entire sample digestion followed by multidimensional LC separation of peptides. Blue
represents the classical gel approach, with or without (dashed arrows) peptide LC. Red combines protein and peptide LC.
(C) Data-dependent MS/MS analysis. Here, ESI of a liquid sample and alternation of the instrument between MS and MS/MS modes is illustrated. The
data generated is a sequence of peptide experimental m/z associated with the corresponding fragments m/z. The complete analysis is named an LC-MS
run.
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detailed explanation of the peptide fragmentation process is
not within the scope of this paper. Nevertheless, brieﬂy, two
molecules (preﬁx and sufﬁx) are created when a peptide is
fragmented. As the fragmentation process can occur on
multiple copies of the peptide, many (albeit not all) preﬁx
and sufﬁx ions are observed. Fragmentation, however, is not
possible throughout the entirety of the peptide. Only well-
deﬁned ion types (a,b,c,x,y,z) are generally observed (see
Figure 4A and 4B). Depending on the amino acid
composition, some fragments can lose a water or ammonia
molecule (a neutral loss) that results in b-H2O, b-NH3, y-H2O,
etc., fragments. Consequently, given a peptide sequence,
there are rules for computing theoretical fragment masses,
and it is possible to compare theoretical and experimental
MS/MS spectra during a database search (see Figure 5). Based
on the peptides identiﬁed, protein identiﬁcation can be
deduced by mapping the observed peptides onto the protein
sequences (see Figure 6). A program (Text S5) and a mass list
(Text S6) are provided to illustrate the implementation of
MS/MS database searching.
The ability to identify individual peptides enables the
analysis of complex peptide mixtures, as the peptides can be
readily separated by LC. As was the requirement for PMF,
with this approach it is no longer necessary that all peptides
from a protein be contained within a single spectrum. A
standard procedure is to analyze a liquid sample with an LC-
ESI-MS/MS instrument in data-dependent mode. That is, the
peptides are separated by an LC column, and the liquid phase
containing the peptides is continuously introduced and
ionized in the source of the mass spectrometer. The
instrument in effect then ‘‘scans’’ the ﬂuid for peptides by
alternating between MS and MS/MS acquisitions. Peptide
masses are acquired in MS mode, and a predeﬁned number of
the most intense peaks are selected for fragmentation in MS/
MS mode. The instrument then returns to MS mode, and the
alternating cycle continues. See Figure 1C.
The ﬂexibility obtained by the analytical procedure
described above is exploited in shotgun proteomics [17].
doi:10.1371/journal.pcbi.0030114.g003
Figure 3. Peak Detection
(A) Shown in this magnified region of a MALDI–PMF spectrum are the signals generated by peptides. The spectrum is acquired from a mixture of several
peptides. Multiple copies of each peptide are present simultaneously. Multiple copies of a peptide (each detected with a small mass error) result in the
essentially Gaussian shape of the peaks. Each copy comprises atoms containing different isotopes. Finally, one peptide yields several peaks with relative
intensities that match the relative probabilities of the observed isotopes. The monoisotopic peak, i.e., the first peak, is relevant for mass computation. It
is noteworthy to mention that the signal is noisy and the sampling limited. Shown in red is a model of a complete peptide signal fit to the experimental
data. From the model location m, the mass can be directly deduced and detection of isotopes as additional peptide masses is avoided. The green line is
an estimation of the local noise level.
(B) Principle of the model.
doi:10.1371/journal.pcbi.0030114.g002
Figure 2. Peptide Mass Fingerprinting Database Search Algorithm
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digested in its entirety. The complete digest is then analysed
by multidimensional peptide LC. Peptides from one single
protein are dispersed over many LC fractions.
MS/MS Scoring Functions
The comparison of theoretical and experimental MS/MS
spectra is performed by a scoring function, and the score
(ideally complemented by a p-value) is used to recognize the
correct peptide from a database. Reliable peptide
identiﬁcations can then be considered for protein
identiﬁcation.
The most intuitive notion of score is provided by shared
peak count (SPC), i.e., the number of masses shared by
experimental and theoretical spectra within a given mass
tolerance d. In practice, SPC does not perform well. All
matched masses are weighted identically, although some are
more reliable (i.e., informative) than other masses. For
example, peptide fragmentation creates several fragment ion
types (see Figure 4B), and some are detected more frequently
than others. Therefore, the presence/absence of frequently
observed fragments should contribute more to the score
compared with fragments that are seldom observed. SPC also
suffers from other limitations. Some ‘‘global’’ properties of
correct matches are ignored, e.g., the series of consecutive
fragments detected and the peak intensities (see Figure 5). A
high-quality scoring function should capture some of the
properties that characterize a correct identiﬁcation; namely,
to match as many reliable fragments as possible (typically b/y),
to explain the most intense peaks, and to contain some global
pattern. Presented below are the scoring functions of three
well-accepted search engines.
SEQUEST [18] (Thermo Scientiﬁc, http://www.thermo.com)
scoring function is heuristic in nature. In fact, SEQUEST uses
two scoring functions. The initial one is used to rapidly
determine the best 200 peptide candidates for each MS
spectrum, and a second function rescores the 200 hits. The
computation of the initial score Sp is performed by the
formula (simpliﬁed, no immonium ions)
doi:10.1371/journal.pcbi.0030114.g004
Figure 4. Peptide Theoretical Mass Computation and Fragmentation
(A) As illustrated, the peptide atomic composition is dependent on the residue Ri and on fixed atoms (H2O). Therefore, once the peptide sequence is
known, it is possible to sum the mass of each amino acid and add the mass of a water molecule to determine the theoretical mass of the peptide. If
some amino acid residues are modified, mass shifts are added to the unmodified peptide mass.
(B) Peptides fragment at specific locations named a,b,c,x,y,z. N-terminal fragments are termed ai,bi,ci, where i denotes the number of amino acids in the
fragment. Similarly, the complementary C-terminal fragments are termed xn 1,yn 1,zn 1, n is the peptide length.
(C) Example of fragment mass computation.
(D) The same example as in (C) with phosphorylated threonine residues (þ79.9663 Da). Note that all fragment ions including the ion with one or two
threonine residues are shifted in mass once or twice, respectively.







im is the sum of matched fragment ion intensities, nm
is the number of matched fragment ions, nT is the total
number of fragment ions. The factor b rewards the continuity
of a fragment series (contiguous matches); b has an initial
value of 0 and is incremented by a small value each time
successive b or y ion matches are found. See the SEQUEST
patent [19] for possible b values. Obviously, Sp score
comprises the properties of correct matches as described
above. Note also the division by nT, the role of which is to
avoid artifactual high scores with long peptide sequences and/
or long experimental mass lists.
The ﬁnal SEQUEST score computation is achieved by
converting the theoretical fragment masses into an artiﬁcial
spectrum and by computing a cross-correlation (a*e)(t)
between the artiﬁcial spectrum a and the experimental mass
list e, with delay t:
ða   eÞðtÞ¼
X N
i¼0




where E(.) denotes the mean. To take into account possible
random matches and to rescale score values onto [0;1], the
ﬁnal SEQUEST score is deﬁned as
Xcorr ¼
ða   eÞð0Þ Efða   eÞðtÞ;t 2½   75;75 g
ða   aÞð0Þ Efða   aÞðtÞ;t 2½   75;75 g
:
In addition to the Xcorr score, SEQUEST exports several
other factors, e.g., Sp and the difference between the best and
second-best scores. Several authors have utilised this
information to develop machine learning methods to detect
patterns that are characteristic of correct and false matches
[20–22]. These meta-scores are usually an improvement over
Xcorr.
Mascot [23] (Matrix Science, http://www.matrixscience.com)
scoring has never been published nor patented. It involves
the selection of two fragment ion types, where most fragment
matches are observed, and a probability-based score is
computed on the basis of these two fragment types only.
Experimental mass list pre-processing is also part of the
Mascot algorithm. Mascot score is the negative logarithm of a
p-value. The latter pre-processing and the selection of two
fragment types are intended to obtain a more robust scoring
system.
The last approach presented here is based on likelihood
ratios [24]. It is assumed that the fragment matches constitute
independent Bernoulli events, and the probability of these
events depends on the fragment type h 2 S only, where S ¼
fa,b,y,...,g is the set of possible fragment types. This
probability is denoted as ph.I fs¼a1...an is a peptide sequence
and ai the constituent amino acids, then the probability of a
correct match between s and an experimental spectrum is
estimated by taking the product of ph for every matched
fragment and of 1   ph for every unmatched fragment. The
null-model is identical with random fragment match
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S(s, i)   S is the set of fragment types ending at amino acid
ai, M(s, i)   S(s, i) is the set of fragment types matching the
experimental fragment mass. S(s, i) may be a proper subset of
S because certain fragments are not always possible
depending on their amino acid composition (neutral loss).
Probabilities, ph, h 2 S are learnt from a set of correct
doi:10.1371/journal.pcbi.0030114.g006
Figure 6. MS/MS Database Search Algorithm
In this simplified MS/MS search algorithm, we assume that the peptide charge states are unknown and that all possible values (1–4 typically) need to be
assessed. In practice, charge state determination is dependent on instrument mass resolution. Additionally, it is common that the charge is known for
some, but not all, peptides.
doi:10.1371/journal.pcbi.0030114.g005
Figure 5. Peptide Match
Match of an experimental spectrum with a peptide sequence. All
theoretical fragment masses (within a given mass tolerance) observed in
the experimental data are represented by a coloured disk. As is often the
case, it is clear that not all fragment types are detected. Some neutral
losses are not possible depending on the fragment amino acids (shown
by a dot). Structural properties of the match are apparent, i.e.,
consecutive fragment ion matches (albeit with ‘‘holes’’); and more
intense b and y fragments (indicated by the colour, peak intensity
relative order scale on the right with relative count of matched peaks).
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learnt from random peptides. Preferably, only the fragment
types with probabilities ph and rh sufﬁciently different are
actually used in the scoring function L.
This approach can be extended by introducing more
complex models that capture additional properties of correct
and random peptide matches [25–27]. A hidden Markov
model (HMM) was used to model sequences of consecutive
fragment matches with mismatch tolerance (Figure 7) and
models similar to Equation 1 to model peak intensities and
the inﬂuence of amino acid composition [27]. These scoring
functions are implemented in Phenyx (Geneva
Bioinformatics, http://www.genebio.com), and some
performance comparisons can be found in Colinge et al. [27]
and Heller et al. [28].
Modified Peptides
It is possible that some amino acids are modiﬁed (PTMs,
chemical modiﬁcations), resulting in mass shifts. Such
changes in mass need to be taken into account to correctly
compute theoretical MS/MS spectra. The simplest cases are
ﬁxed modiﬁcations, e.g., carboxyamidomethyl cysteine
(þ57.02146 Da). All cysteine residues in a protein are reduced
(i.e., the disulﬁde bonds are broken) and the nominal amino
acid mass is replaced by a shifted mass in all computations.
There are also variable modiﬁcations that are not present
systematically. In this case, it is necessary to compute several
theoretical spectra to cover all eventualities (see Figure 4D). A
common example of a variable modiﬁcation is oxidation of
methionine residues (þ15.9945 Da). Such a modiﬁcation is
almost always possible and would mask peptide
identiﬁcations if ignored.
In practice it is not feasible to allow many variable
modiﬁcations when searching mass spectrometric–generated
data against a database. Search space and time is markedly
increased as is the false positive rate.
Protein Identification
Obtaining reliable peptide identiﬁcations is an essential
step toward reliable protein identiﬁcations; however, some
additional aspects need to be taken into consideration. Most
of the problems associated with protein identiﬁcation are
caused by peptides shared by several proteins; see Figure 8 for
an example. When two or more sequences in the database are
identiﬁed on the basis of the same peptides, then it is
impossible to know with certainty which molecule(s) is(are)
present in the sample. This problem has been discussed
extensively by A. Nesvizshkii and R. Aebersold [29].
To assign a score to a protein identiﬁcation is an open
question, as there are many options. A standard approach is
simply to sum the highest score for each distinct peptide
identiﬁed. Alternatively, it is possible to consider the
multiplicity of spectra matched for each peptide to support
additional evidence [30]. Not to assign a score at all is also an
option, and a list of trusted proteins is the only output in that
case. A classical criterion to accept a protein identiﬁcation is
to detect two distinct peptides above a reasonable peptide
score [31]. A very small number of false positive
identiﬁcations are generated by this approach.
The choice of protein database plays an important role in
MS data identiﬁcation. Classically, either comprehensive or
curated databases have been utilised. As comprehensive
databases, NCBInr (http://www.ncbi.nlm.nih.gov) and Ensembl
[32] are those most frequently used, whereas commonly used
curated databases are UniProtKB/Swiss-Prot [33] and
International Protein Index (IPI) [34]. The latter integrates
several curated databases and aims to include all alternative
splice forms and active fragments. The IPI database offers a
good combination of quality and exhaustiveness, which is
crucial for proteomic data analysis.
Peptide De Novo Sequencing
In the preceding sections, MS data searched against a
protein sequence database was described. Situations also arise
where such a database is not available or is inappropriate. A
classical example is the analysis of a sample from an organism
whose genome is not completely sequenced [35]. A more
doi:10.1371/journal.pcbi.0030114.g007
Figure 7. Consecutive Fragment Matches
To detect sequences of consecutive fragment matches for a given type of fragment, it is possible to use a HMM. A sequence of symbols the length of
the peptide is observed with alphabet letters fm,fg, m for match and f for failed match. The model topology is designed to accommodate for some
missing matches: S1 represents a first uninformed match, whereas S2 and S3 represent matches with preceding matches.
doi:10.1371/journal.pcbi.0030114.g008
Figure 8. Issues in Protein Identification
Complications in identifying proteins. Four proteins (A, B, C, D) are
identified by four distinct peptides (black squares). Although A and B are
different, it is impossible to ascertain which molecule is present, as both
have been identified by the same (shared) peptides. A variation of this is
shown in C. Protein D shares three peptides with A and B, and two with
C, but also has a specific fourth peptide. From this information it can be
concluded that D is in the sample.
PLoS Computational Biology | www.ploscompbiol.org July 2007 | Volume 3 | Issue 7 | e114 1156difﬁcult example is the case where peptides are modiﬁed in
an unexpected manner and hence are not found via the
variable modiﬁcations speciﬁed during the database search.
As consideration of all possible modiﬁcations is not feasible, a
method that would predict part of the unmodiﬁed peptide
sequence would enable the possibility of searching candidate
peptides by homology before conﬁrmation by MS/MS [36,37].
To predict the peptide sequence directly from an MS/MS
spectrum is known as de novo peptide sequencing. To do this
in reality is not straightforward, and prediction of short
reliable sections of the sequence (so-called sequence tags) is
often more realistic. The sequence tags can be used either as
incomplete but reliable sequences or for searching a database
by allowing mismatches. Sequence tags from several peptides
from the same protein can result in speciﬁc identiﬁcation of
the protein.
In the early days of de novo peptide sequencing, algorithms
were developed that attempted to reconstruct peptide
sequences by essentially considering all amino acid
combinations. Such approaches are obviously not applicable
to generic problems. Currently, researchers in the ﬁeld
investigate graph theoretic algorithms, Markov chain Monte
Carlo heuristic optimization, or HMMs. Usually, a
preliminary ﬁltering of the experimental mass list is
performed to remove noisy peaks.
A well-established method involves the computation of a
spectrum graph G. Based on the masses in the experimental
mass list, one vertex per mass is created; two vertices are
linked provided the mass difference equals one amino acid
mass within a given tolerance [38], and the edge is labelled
with the corresponding amino acid (see Figures 9, S1, and S2).
To contend with absent fragments, it may also be necessary to
create edges for mass differences equalling two amino acids.
Moreover, as it is unknown whether an experimental mass is
from a C- or an N-terminal fragment, it may be necessary to
complement each experimental fragment mass (peptide mass
minus fragment mass) as the vertices are constructed. This
general procedure can be adapted in several ways [24,39–41].
Given a spectrum, the problem of predicting the most
plausible peptide sequence can be solved by ﬁnding a longest
path in the spectrum graph [24,40,42]. The length of each
edge is given by a scoring function that measures the ﬁt
between the additional theoretical masses yielded by the edge
and the MS/MS data. Other algorithms use the spectrum
graph to produce candidate peptide sequences that are
progressively extended. This is typically achieved by
iteratively growing and trimming a population of sequences
[41]. It is also possible to combine C- and N-terminal partial
sequences as obtained by a spectrum graph without
computing one longest path [43].
A very different point of view is to deﬁne a scoring
function and to optimize it over the space of all possible
peptide sequences. The optimization is usually performed by
a genetic algorithm [44,45].
A recent and innovative paper models spectral peaks as if
the peaks were generated by a sequential process and hence
applies a HMM [46].
Noisy peak ﬁltering can be achieved by ad hoc methods
that deﬁne noise according to a proportion of the total peaks
or the total signal [39,41]. Alternatively, prediction of the type
of each peak can be attempted, e.g., a,b,y fragment ion. Peaks
that result in a reliable prediction can be included for further
computation [47].
Other Problems
To directly match proteomic data with genome sequences
has attracted signiﬁcant attention because there is the
potential to complement and correct genome annotations by
MS data. This potential is indeed conﬁrmed by new ﬁndings
reported by several authors [48–50].
The problem of genome searching can be approached in
different ways. The most challenging case is to search MS data
against a eukaryotic genome, as peptides can be coded across
doi:10.1371/journal.pcbi.0030114.g009
Figure 9. Spectrum Graph
Spectrum graph of peptide MTDSK. The spectrum contains the b and y
fragment ion masses plus two neutral losses and two peaks generated
from noise. Only one amino acid’s mass differences are accepted. Masses
are complemented and interpreted as b fragments. Even in this
oversimplified case, it is observed that many edges are created in
addition to those that are necessary. In particular, part of the reverse
sequence in the graph is observed. The graph complexity increases
rapidly with real spectra and with two amino acid mass differences
accepted; see also the two examples given in Figures S1 and S2.
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prediction algorithm to obtain protein sequences that are
searched as per a standard protein database. An alternative
method is to use de novo predictions and to search the
predicted sequences by homology. Finally, it is possible to
combine gene structure predictions and MS data searches to
reveal and validate splice sites [51].
Sample comparison is essential in proteomics, and several
methods have been developed to quantitatively evaluate
datasets. With 2-D gels, spot volumes can provide
semiquantitative information [8,52]. It is also possible to label
peptides with speciﬁc reagents that alter the mass by a known
value [53]. Two or more modiﬁed samples are pooled prior to
LC-MS analysis. The mass shifts in the spectra indicate the
origin of the peptide, and relative peak intensities provide
quantitative information.
Label-free methods have been introduced that require
neither 2-D gels nor peptide modiﬁcation. These methods
either sum all the peak intensities of a given peptide during
one LC-MS experiment [54] (extracted ion chromatogram) or
count the number of spectra matching the peptides of a
protein [55,56]. Alternatively, it is possible to use protein
chips to measure protein concentration [57].
In each case, a protein can be assigned an expression
proﬁle across samples, and techniques similar to micro-array
data analysis can be applied.
Despite the great importance of PTMs for biological
function, studies on a large scale are difﬁcult [58,59]. In the
context of computational analyses, comprehensive
approaches toward general PTMs are difﬁcult. Although
many laboratories have undertaken detailed investigations of
a speciﬁc modiﬁcation in the quest to determine answers to a
particular biological question, e.g., phosphorylation events in
signalling pathways, most of these studies have involved
manual or semi-automated annotation of the modiﬁcation
site(s), and data processing is more a matter of storing and
visualizing. Bioinformatics has later contributed in a systems
biology approach by utilising the information gained from
such studies to assign function to the proteins and to reveal
biological interactions.
There are also a number of interesting and important
computational proteomic questions, which are considered
out of the scope of this introduction, and are therefore not
covered. These include protein structure elucidation via MS;
glycan and lipid analysis; direct proﬁling of samples by MS,
i.e., metabolomics. Here masses, not necessarily peptides, are
detected in each sample and are comparatively analysed.
Resources
InSilicoSpectro [60] is an open-source Perl project that
implements many MS-related computations and contains
numerous simple examples illustrating some of the presented
concepts. Two elementary implementations of PMF and MS/
MS database search in Cþþ are provided with example data
(see Text S3 and Text S5).
Phenyx is freely available at http://www.phenyx-ms.com and
Mascot at http://www.matrixscience.com. Two open-source
database search engines have been developed, OMSSA [61]
and X!Tandem [62]. Several public MS/MS data repositories
are accessible over the Internet, including Peptide Atlas




Proteomics plays an ever-increasing and pivotal role in
biological research, and there are a range of technologies
available that can generate large quantities of data. The
analysis of such data opens new and challenging areas of
interest for bioinformatics. In addition to the utilisation of
classical methods and resources, new types of data require
modelling and processing. Perhaps the best example is the
mass spectrum itself, which contains continuous and discrete
information simultaneously. Such issues are reﬂected in the
difﬁculty of designing high-performance scoring functions
and de novo sequencing algorithms.
To provide an introduction to this fascinating ﬁeld of
research, we have presented general concepts of proteomics.
The central problem of MS data identiﬁcation by database
searching has been explained at an introductory level, and
should allow any interested reader to grasp the fundamental
concepts of this area of research. &
Supporting Information
Figure S1. Accepting Pairs of Amino Acid Masses in De Novo
Sequencing
A spectrum graph generated with the same spectrum as in the paper
(peptide MTDSK) but by allowing pairs of amino acid mass
differences. Observe the massive increase in complexity.
Found at doi:10.1371/journal.pcbi.0030114.sg001 (13 KB PDF).
Figure S2. Noise in Mass Spectra Impacts De Novo Sequencing
A graph obtained based on a relatively small real spectrum for the
peptide LRDQLGTAK by only accepting single amino acid mass
differences (all the y fragments are present). This example shows why
it is important to ﬁlter mass lists for noise prior to de novo
prediction, since the spectrum becomes very complex otherwise.
Found at doi:10.1371/journal.pcbi.0030114.sg002 (45 KB PDF).
Text S1. computeMOWSEMatrix.cpp
AC þþ program to implement the computation of the MOWSE
matrix, which is used by the MOWSE PMF scoring function.
Found at doi:10.1371/journal.pcbi.0030114.sd001 (6 KB TXT).
Text S2. MOWSE Matrix
The MOWSE matrix computed by computeMOWSEMatrix.cpp (see
Text S1).
Found at doi:10.1371/journal.pcbi.0030114.sd002 (10 KB TXT).
Text S3. pmfDBSearch.cpp
AC þþ program implementing a minimal PMF database search
algorithm.
Found at doi:10.1371/journal.pcbi.0030114.sd003 (18 KB TXT).
Text S4. A PMF Mass List
An example mass list for PMF searching (in pkl format, SWISS-PROT
ID: ENO_YEAST).
Found at doi:10.1371/journal.pcbi.0030114.sd004 (1 KB TXT).
Text S5. msmsDBSearch.cpp
AC þþ program implementing a minimal MS/MS database search
algorithm.
Found at doi:10.1371/journal.pcbi.0030114.sd005 (23 KB TXT).
Text S6. An MS/MS Mass List
An example mass list for MS/MS searching (in mgf format, SWISS-
PROT ID: ENO_YEAST).
Found at doi:10.1371/journal.pcbi.0030114.sd006 (22 KB TXT).
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